Knowledge (XXG)

TOP1

Source 📝

369: 346: 2967: 2922: 2937: 2952: 2832: 243: 268: 2847: 2757: 2907: 2892: 2817: 2877: 2802: 375: 274: 40: 2862: 2772: 2787: 1379:, which inhibit TOP1, are among the most effective FDA-approved anticancer chemotherapeutic agents used in clinical practice. Higher expression of TOP1 in KRAS mutant non-small cell lung cancer and correlation to survival suggests that TOP1 inhibitors might have increased benefit when administered to treat patients with a KRAS mutant tumor. 1243:
This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This enzyme catalyzes the transient breaking and rejoining of a single strand of DNA which lets the broken strand rotate around the intact strand, thus altering the topology of
1260:
were found to nick the DNA with a preference for a sequence of nucleotides that extends from positions -4 to -1 from the nick. The preferred nucleotides in the strand to be cut are 5'-(A/T)(G/C)(A/T)T-3' with the enzyme covalently attached to the -1 T residue, though sometimes a C residue is found
1524:
is a metastasis-suppressor gene in prostate cancer, and appears to have a role in DNA repair. Screening of 3360 compounds revealed that irinotecan-mediated TOP1 deficiency (and one other compound, cetrimonium bromide) exhibit synthetic lethality with NDRG1 deficiency in prostate cancer cells.
66: 1358:
act by trapping a subset of TOP1-DNA cleavage complexes, those with a guanine +1 in the DNA sequence. One irinotecan or SN-38 molecule stacks against the base pairs flanking the topoisomerase-induced cleavage site and poisons (inactivates) the TOP1 enzyme. The article
1252:
As reviewed by Champoux, the type IB topoisomerases, including TOP1, form a covalent intermediate in which the active site tyrosine becomes attached to the 3' phosphate end of the cleaved strand rather than the 5' phosphate end.
2966: 2921: 1510:
and in a mouse model caused increased sensitivity to inactivation by irinotecan compared to cells with high expression of ATM. This indicates synthetic lethality of ATM deficiency with irinotecan-mediated TOP1 deficiency.
2936: 2951: 2831: 2846: 2331:
Andersen FF, Tange TØ, Sinnathamby T, Olesen JR, Andersen KE, Westergaard O, Kjems J, Knudsen BR (Sep 2002). "The RNA splicing factor ASF/SF2 inhibits human topoisomerase I mediated DNA relaxation".
1312:
of the DNA is relaxed by controlled rotation of DNA about the intact strand. Then the 5' hydroxyl end of the broken DNA strand can reverse the phosphotyrosyl bond, enabling the release of TOP1 and
1390:
arises when a combination of deficiencies in the expression of two or more genes leads to cell death, whereas a deficiency in only one of these genes does not. The deficiencies can arise through
1330:
The briefly attached, covalently bonded TOP1-DNA structure at the 3' end of a cleaved DNA single strand is called a TOP1-DNA cleavage complex, or TOP1cc. The TOP1cc is a specific target of TOP1
2255:
Subramanian, D.; Rosenstein, B. S.; Muller, M. T. (1998). "Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: Possible relationship with DNA repair".
2048:
Pavelitz T, Renfro L, Foster NR, Caracol A, Welsch P, Lao VV, Grady WB, Niedzwiecki D, Saltz LB, Bertagnolli MM, Goldberg RM, Rabinovitch PS, Emond M, Monnat RJ, Maizels N (2014).
2756: 1286:
within the N-terminal domain. The N-terminal domain is followed by a highly conserved, 421 amino acid core domain containing all of the catalytic residues except the active site
2906: 2891: 2050:"MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial" 1986:
Agrelo R, Cheng WH, Setien F, Ropero S, Espada J, Fraga MF, Herranz M, Paz MF, Sanchez-Cespedes M, Artiga MJ, Guerrero D, Castells A, von Kobbe C, Bohr VA, Esteller M (2006).
2284:"Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor" 1461:
of 5-fluorouracil/leucovorin (FU/LV) or else with irinotecan+FU/LV and were followed up for 8 years. Eleven percent of the tumors were deficient for DNA repair enzyme
382: 281: 2816: 1514:
Another pre-clinical effort was a screening study to find a compound that would be synthetically lethal with a deficiency of N-myc downstream regulated gene 1 (
954: 935: 204: 1401:
Irinotecan inactivation of TOP1 appears to be synthetically lethal in combination with deficiencies in expression of some specific DNA repair genes.
2112:"ATM expression predicts Veliparib and Irinotecan sensitivity in gastric cancer by mediating P53 independent regulation of cell cycle and apoptosis" 2876: 2801: 1405: 2995: 2736: 1690: 1672: 2156:"Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells" 1454:. A recent study was carried out with 1,264 patients with stage III colon cancer. The patients were treated with a postoperative weekly 2975:: Human DNA topoisomerase I (70 kDa) in complex with the indenoisoquinoline AI-III-52 and covalent complex with a 22 base pair DNA duplex 2930:: Human DNA Topoisomerase I (70 Kda) In Complex With The Indenoisoquinoline MJ-II-38 and Covalent Complex With A 22 Base Pair DNA Duplex 368: 1161: 1154: 1290:. This is followed by a poorly conserved linker domain of 77 amino acids. Finally there is a 53 amino acid C-terminal domain. The 1429:
gene promoters, so that WRN protein expression was high. Irinotecan was more strongly beneficial for patients with hypermethylated
2945:: Human DNA Topoisomerase I (70 Kda) In Complex With The Indolocarbazole SA315F and Covalent Complex With A 22 Base Pair DNA Duplex 345: 2154:
Wissing MD, Mendonca J, Kim E, Kim E, Shim JS, Kaelber NS, Kant H, Hammers H, Commes T, Van Diest PJ, Liu JO, Kachhap SK (2013).
1764: 2960:: Human DNA Topoisomerase I (70 Kda) In Complex With The Poison Camptothecin and Covalent Complex With A 22 Base Pair DNA Duplex 1283: 2371:"Characterization of BTBD1 and BTBD2, two similar BTB-domain-containing Kelch-like proteins that interact with Topoisomerase I" 1659: 1638: 1477:(though the effect was small), indicating some degree of synthetic lethality between irinotecan-induced TOP1 inactivation and 2840:: HUMAN DNA TOPOISOMERASE I (70 KDA) IN COMPLEX WITH THE POISON TOPOTECAN AND COVALENT COMPLEX WITH A 22 BASE PAIR DNA DUPLEX 267: 242: 2861: 1655: 63: 2771: 1279: 1634: 1313: 184: 2855:: Human DNA Topoisomerase I (70 Kda) In Non-Covalent Complex With A 22 Base Pair DNA Duplex Containing an 8-oxoG Lesion 1554: 1503: 1493: 1485: 1375:
Since 1985, TOP1 has been known as a target for the treatment of human cancers. Camptothecin analogues irinotecan and
1308:
that attacks the DNA phosphodiester backbone. After the TOP1 covalently attaches to the 3' end of the broken strand,
2512:"The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53" 2786: 381: 280: 1542: 2205:"mTOR regulates the expression of DNA damage response enzymes in long-lived Snell dwarf, GHRKO, and PAPPA-KO mice" 2729: 1926:"KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer" 1499: 374: 273: 999: 192: 1364: 1331: 1325: 980: 1875:
Liu YQ, Li WQ, Morris-Natschke SL, Qian K, Yang L, Zhu GX, Wu XB, Chen AL, Zhang SY, Nan X, Lee KH (2015).
1924:
Nagy, Ádám; Pongor, Lőrinc Sándor; Szabó, András; Santarpia, Mariacarmela; Győrffy, Balázs (2017-02-15).
1448:
Irinotecan inactivation of TOP1 may be synthetically lethal with deficient expression of DNA repair gene
2634:"SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage" 256: 1815:"A kinetic clutch governs religation by type IB topoisomerases and determines camptothecin sensitivity" 1244:
DNA. This gene is localized to chromosome 20 and has pseudogenes which reside on chromosomes 1 and 22.
2722: 2645: 2582: 2523: 2061: 1999: 1826: 1606: 1404:
Irinotecan inactivation of TOP1 was synthetically lethal with deficient expression of the DNA repair
1257: 171: 1537:
irradiation specifically stimulates the formation of covalent complexes between topoisomerase I and
1316:
of the DNA. The nicking and closing reactions are fast, and about 100 cycles can occur per second.
1418: 1387: 1301: 1489: 1395: 216: 1137: 1116: 1090: 1069: 1473:-deficient patients having better long-term disease free survival than patients with wild-type 2694: 2673: 2610: 2571:"Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status" 2551: 2492: 2451: 2402: 2348: 2313: 2264: 2234: 2185: 2133: 2089: 2027: 1963: 1945: 1906: 1854: 1795: 1746: 1442: 1347: 1228: 164: 56: 2765:: HUMAN RECONSTITUTED DNA TOPOISOMERASE I IN COVALENT COMPLEX WITH A 22 BASE PAIR DNA DUPLEX 2663: 2653: 2600: 2590: 2541: 2531: 2482: 2441: 2433: 2392: 2382: 2340: 2303: 2295: 2224: 2216: 2175: 2167: 2123: 2079: 2069: 2017: 2007: 1953: 1937: 1896: 1888: 1844: 1834: 1787: 1736: 1728: 1458: 1455: 461: 392: 336: 291: 1411: 1410:
gene in patients with colon cancer. In a 2006 study, 45 patients had colonic tumors with
436: 212: 2915:: Structural Mechanisms of Camptothecin Resistance by Mutations in Human Topoisomerase I 2900:: Structural Mechanisms of Camptothecin Resistance by Mutations in Human Topoisomerase I 2649: 2586: 2527: 2065: 2003: 1830: 2229: 2204: 2180: 2155: 2084: 2049: 2022: 1987: 1958: 1925: 1901: 1876: 1849: 1814: 1741: 1716: 1506:). A 2016 study showed that low expression of the ATM protein in gastric cancer cells 2605: 2570: 2446: 2422:"Interaction between the N-terminus of human topoisomerase I and SV40 large T antigen" 2421: 2344: 2308: 2283: 1231:, an enzyme that catalyzes the transient breaking and rejoining of a single strand of 869: 864: 859: 854: 849: 844: 839: 834: 829: 824: 819: 814: 809: 793: 788: 783: 778: 773: 768: 763: 758: 753: 748: 743: 738: 722: 717: 712: 707: 702: 697: 692: 687: 682: 677: 672: 667: 662: 657: 652: 39: 2989: 2703: 2668: 2633: 2546: 2511: 2397: 2370: 2110:
Subhash VV, Tan SH, Yeo MS, Yan FL, Peethala PC, Liem N, Krishnan V, Yong WP (2016).
1988:"Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer" 1791: 1611: 1309: 1269: 639: 1360: 1339: 454: 233: 2128: 2111: 196: 2074: 1469:
gene. The addition of irinotecan to FU/LV in the treatment protocol resulted in
220: 2369:
Xu L, Yang L, Hashimoto K, Anderson M, Kohlhagen G, Pommier Y, D'Arpa P (2002).
1695:
National Center for Biotechnology Information, U.S. National Library of Medicine
1677:
National Center for Biotechnology Information, U.S. National Library of Medicine
1534: 1305: 1291: 2638:
Proceedings of the National Academy of Sciences of the United States of America
2575:
Proceedings of the National Academy of Sciences of the United States of America
2516:
Proceedings of the National Academy of Sciences of the United States of America
1300:
As further summarized by Pommier and by Seol et al., TOP1 breaks the DNA by a
537: 17: 2825:: HUMAN DNA TOPOISOMERASE I IN COVALENT COMPLEX WITH A 22 BASE PAIR DNA DUPLEX 1778:
Champoux JJ (2001). "DNA topoisomerases: structure, function, and mechanism".
1492:
DNA repair deficiencies common in cancers. For instance, the DNA repair gene
1335: 1265: 353: 250: 200: 2536: 2299: 1949: 2629: 2437: 2282:
Labourier E, Rossi F, Gallouzi IE, Allemand E, Divita G, Tazi J (Jun 1998).
2012: 1839: 1580: 1376: 899: 597: 475: 420: 407: 319: 306: 208: 2677: 2658: 2614: 2595: 2555: 2487: 2470: 2406: 2352: 2238: 2189: 2137: 2093: 2031: 1967: 1910: 1858: 1799: 1750: 1488:
studies indicating synthetic lethality of irinotecan with other genetic or
2496: 2455: 2387: 2317: 2268: 1201: 1196: 1391: 1294: 1287: 1274: 1185: 1044: 1025: 2708: 2698: 2220: 1562: 1465:
due to a deletion of a string of thymidines in the DNA sequence of the
1011: 966: 2171: 1941: 1892: 1732: 1264:
The TOP1 protein of humans has been subdivided into four regions. The
789:
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex
653:
DNA topoisomerase type I (single strand cut, ATP-independent) activity
141: 137: 133: 129: 125: 121: 117: 113: 109: 105: 101: 97: 93: 89: 85: 2471:"Identification of a nucleolin binding site in human topoisomerase I" 1462: 1450: 1217: 1169: 921: 723:
RNA polymerase II cis-regulatory region sequence-specific DNA binding
1592: 1574: 1568: 1516: 1433:
promoters (39.4 months survival) than for those with unmethylated
1355: 1351: 884: 880: 1224: 188: 2718: 1545:, a process that removes UVB-induced, and other, DNA damages. 1338:. Irinotecan is an analogue of the cytotoxic natural alkaloid 2714: 1877:"Perspectives on biologically active camptothecin derivatives" 1586: 1538: 1232: 2693:
Overview of all the structural information available in the
2885:: Human topoisomerase I (Topo70) double mutant K532R/Y723F 1425:
expression), and 43 patients had tumors with unmethylated
2203:
Dominick G, Bowman J, Li X, Miller RA, Garcia GG (2016).
2810:: CRYSTAL STRUCTURE OF HUMAN TOPOISOMERASE I DNA COMPLEX 444: 1334:. One of the first inhibitors shown to target TOP1 is 2420:
Haluska P, Saleem A, Edwards TK, Rubin EH (Apr 1998).
1363:
lists other analogues of camptothecin and the article
1541:. Topoisomerase I appears to have a direct role in 609: 2469:Bharti AK, Olson MO, Kufe DW, Rubin EH (Jan 1996). 1130: 1109: 1083: 1062: 2250: 2248: 1651: 1649: 1647: 1630: 1628: 1626: 1346:. Irinotecan is especially effective through its 1268:214 amino acids are dispensable for relaxation of 175:, TOPI, topoisomerase (DNA) I, DNA topoisomerase I 1717:"Drugging topoisomerases: lessons and challenges" 1441:gene promoter is hypermethylated in about 38% of 391: 290: 2510:Gobert C, Skladanowski A, Larsen AK (Aug 1999). 2364: 2362: 1304:reaction using the active site tyrosine as the 1813:Seol Y, Zhang H, Pommier Y, Neuman KC (2012). 1656:GRCm38: Ensembl release 89: ENSMUSG00000070544 2730: 8: 2043: 2041: 1635:GRCh38: Ensembl release 89: ENSG00000198900 1297:723 is found within the C-terminal domain. 673:core promoter sequence-specific DNA binding 2737: 2723: 2715: 2149: 2147: 2105: 2103: 1367:lists other compounds which inhibit TOP1. 895: 635: 432: 331: 228: 74: 2667: 2657: 2604: 2594: 2545: 2535: 2486: 2445: 2396: 2386: 2307: 2228: 2179: 2127: 2083: 2073: 2021: 2011: 1981: 1979: 1977: 1957: 1900: 1848: 1838: 1765:"Entrez Gene: TOP1 topoisomerase (DNA) I" 1740: 1710: 1708: 1706: 1704: 1398:or by inhibition of a gene's expression. 1284:interaction with other cellular proteins 703:protein serine/threonine kinase activity 2752: 1622: 1437:promoters (20.7 months survival). The 845:circadian regulation of gene expression 2569:Mao Y, Mehl IR, Muller MT (Feb 2002). 29: 2870:: Human Topoisomerase I Ara-C Complex 1870: 1868: 396: 357: 352: 295: 254: 249: 7: 2780:: HUMAN TOPOISOMERASE I/DNA COMPLEX 2475:The Journal of Biological Chemistry 754:replication fork protection complex 1504:hypermethylation of ATM in cancers 1127: 1106: 1080: 1059: 1035: 1016: 990: 971: 945: 926: 614: 532: 470: 449: 25: 1342:, obtained from the Chinese tree 1220:that in humans is encoded by the 2965: 2950: 2935: 2920: 2905: 2890: 2875: 2860: 2845: 2830: 2815: 2800: 2785: 2770: 2755: 1792:10.1146/annurev.biochem.70.1.369 1533:Exposure of human HeLA cells to 1502:(silenced) in many cancers (see 380: 373: 367: 344: 279: 272: 266: 241: 38: 1930:International Journal of Cancer 870:peptidyl-serine phosphorylation 713:protein domain specific binding 598:More reference expression data 1: 2795:: TOPOISOMERASE I/DNA COMPLEX 2707:(DNA topoisomerase 1) at the 2345:10.1016/s0022-2836(02)00815-x 2129:10.1158/1535-7163.MCT-15-1002 365: 264: 2996:Genes on human chromosome 20 2333:Journal of Molecular Biology 2075:10.1371/journal.pone.0108483 1992:Proc. Natl. Acad. Sci. U.S.A 1819:Proc. Natl. Acad. Sci. U.S.A 1280:nuclear localization signals 698:single-stranded DNA binding 693:double-stranded DNA binding 3012: 1543:nucleotide excision repair 1323: 668:DNA topoisomerase activity 518:superior surface of tongue 2750: 1691:"Mouse PubMed Reference:" 1673:"Human PubMed Reference:" 1200: 1195: 1191: 1184: 1168: 1162:Chr 2: 160.49 – 160.56 Mb 1149: 1134: 1113: 1102: 1087: 1066: 1055: 1042: 1038: 1023: 1019: 1010: 997: 993: 978: 974: 965: 952: 948: 933: 929: 920: 905: 898: 894: 878: 638: 634: 622: 617: 608: 595: 544: 535: 482: 473: 443: 435: 431: 414: 401: 364: 343: 334: 330: 313: 300: 263: 240: 231: 227: 182: 179: 169: 162: 157: 82: 77: 60: 55: 50: 46: 37: 32: 2628:Mao Y, Sun M, Desai SD, 2537:10.1073/pnas.96.18.10355 1155:Chr 20: 41.03 – 41.12 Mb 27:DNA topoisomerase enzyme 2013:10.1073/pnas.0600645103 1840:10.1073/pnas.1206480109 1553:TOP1 has been shown to 1365:Topoisomerase inhibitor 1326:Topoisomerase inhibitor 718:supercoiled DNA binding 2659:10.1073/pnas.080536597 2596:10.1073/pnas.022631899 2488:10.1074/jbc.271.4.1993 2426:Nucleic Acids Research 2300:10.1093/nar/26.12.2955 2288:Nucleic Acids Research 1484:There are a number of 865:DNA topological change 835:chromosome segregation 514:pancreatic ductal cell 2438:10.1093/nar/26.7.1841 2388:10.1186/1471-2164-3-1 1396:epigenetic alteration 1344:Camptotheca acuminata 820:programmed cell death 564:mandibular prominence 257:Chromosome 20 (human) 1607:Type I topoisomerase 1261:at the -1 position. 810:chromatin remodeling 560:maxillary prominence 398:2 H2|2 80.96 cM 359:Chromosome 2 (mouse) 78:List of PDB id codes 51:Available structures 2650:2000PNAS...97.4046M 2587:2002PNAS...99.1235M 2528:1999PNAS...9610355G 2066:2014PLoSO...9j8483P 2004:2006PNAS..103.8822A 1831:2012PNAS..10916125S 1388:Synthetic lethality 1383:Synthetic lethality 1302:transesterification 1278:and there are four 1214:DNA topoisomerase 1 840:protein sumoylation 794:protein-DNA complex 584:ganglionic eminence 494:ganglionic eminence 2221:10.1111/acel.12525 1780:Annu. Rev. Biochem 1715:Pommier Y (2013). 1443:colorectal cancers 1354:. Irinotecan and 1000:ENSMUSG00000070544 815:embryonic cleavage 803:Biological process 764:nuclear chromosome 732:Cellular component 663:isomerase activity 646:Molecular function 2983: 2982: 2172:10.4161/cbt.23759 2160:Cancer Biol. Ther 2122:(12): 3087–3096. 1942:10.1002/ijc.30509 1893:10.1002/med.21342 1733:10.1021/cb300648v 1229:DNA topoisomerase 1211: 1210: 1207: 1206: 1180: 1179: 1145: 1144: 1124: 1123: 1098: 1097: 1077: 1076: 1051: 1050: 1032: 1031: 1006: 1005: 987: 986: 961: 960: 942: 941: 890: 889: 658:chromatin binding 630: 629: 626: 625: 604: 603: 591: 590: 529: 528: 427: 426: 326: 325: 153: 152: 149: 148: 61:Ortholog search: 16:(Redirected from 3003: 2969: 2954: 2939: 2924: 2909: 2894: 2879: 2864: 2849: 2834: 2819: 2804: 2789: 2774: 2759: 2739: 2732: 2725: 2716: 2682: 2681: 2671: 2661: 2625: 2619: 2618: 2608: 2598: 2566: 2560: 2559: 2549: 2539: 2522:(18): 10355–60. 2507: 2501: 2500: 2490: 2466: 2460: 2459: 2449: 2417: 2411: 2410: 2400: 2390: 2366: 2357: 2356: 2328: 2322: 2321: 2311: 2279: 2273: 2272: 2252: 2243: 2242: 2232: 2200: 2194: 2193: 2183: 2151: 2142: 2141: 2131: 2116:Mol. Cancer Ther 2107: 2098: 2097: 2087: 2077: 2045: 2036: 2035: 2025: 2015: 1983: 1972: 1971: 1961: 1921: 1915: 1914: 1904: 1872: 1863: 1862: 1852: 1842: 1825:(40): 16125–30. 1810: 1804: 1803: 1775: 1769: 1768: 1761: 1755: 1754: 1744: 1712: 1699: 1698: 1687: 1681: 1680: 1669: 1663: 1653: 1642: 1632: 1258:topoisomerases I 1193: 1192: 1164: 1157: 1140: 1128: 1119: 1107: 1103:RefSeq (protein) 1093: 1081: 1072: 1060: 1036: 1017: 991: 972: 946: 927: 896: 855:circadian rhythm 830:rhythmic process 774:fibrillar center 636: 615: 600: 580:ventricular zone 576:genital tubercle 556:secondary oocyte 548:Ileal epithelium 540: 538:Top expressed in 533: 498:secondary oocyte 490:ventricular zone 478: 476:Top expressed in 471: 450: 433: 423: 410: 399: 384: 377: 371: 360: 348: 332: 322: 309: 298: 283: 276: 270: 259: 245: 229: 223: 221:TOP1 - orthologs 174: 167: 144: 75: 69: 48: 47: 42: 30: 21: 3011: 3010: 3006: 3005: 3004: 3002: 3001: 3000: 2986: 2985: 2984: 2979: 2976: 2970: 2961: 2955: 2946: 2940: 2931: 2925: 2916: 2910: 2901: 2895: 2886: 2880: 2871: 2865: 2856: 2850: 2841: 2835: 2826: 2820: 2811: 2805: 2796: 2790: 2781: 2775: 2766: 2760: 2746: 2743: 2690: 2685: 2627: 2626: 2622: 2568: 2567: 2563: 2509: 2508: 2504: 2468: 2467: 2463: 2419: 2418: 2414: 2368: 2367: 2360: 2330: 2329: 2325: 2294:(12): 2955–62. 2281: 2280: 2276: 2257:Cancer Research 2254: 2253: 2246: 2202: 2201: 2197: 2153: 2152: 2145: 2109: 2108: 2101: 2060:(10): e108483. 2047: 2046: 2039: 1985: 1984: 1975: 1923: 1922: 1918: 1874: 1873: 1866: 1812: 1811: 1807: 1777: 1776: 1772: 1763: 1762: 1758: 1714: 1713: 1702: 1689: 1688: 1684: 1671: 1670: 1666: 1654: 1645: 1633: 1624: 1620: 1603: 1598: 1551: 1531: 1520:) expression. 1500:hypermethylated 1412:hypermethylated 1385: 1373: 1328: 1322: 1256:The eukaryotic 1250: 1241: 1202:View/Edit Mouse 1197:View/Edit Human 1160: 1153: 1150:Location (UCSC) 1136: 1115: 1089: 1068: 981:ENSG00000198900 874: 850:DNA replication 825:phosphorylation 798: 727: 678:protein binding 596: 587: 582: 578: 574: 570: 566: 562: 558: 554: 550: 536: 525: 520: 516: 512: 508: 504: 500: 496: 492: 488: 474: 418: 405: 397: 387: 386: 385: 378: 358: 335:Gene location ( 317: 304: 296: 286: 285: 284: 277: 255: 232:Gene location ( 183: 170: 163: 84: 62: 28: 23: 22: 18:Topoisomerase I 15: 12: 11: 5: 3009: 3007: 2999: 2998: 2988: 2987: 2981: 2980: 2978: 2977: 2971: 2964: 2962: 2956: 2949: 2947: 2941: 2934: 2932: 2926: 2919: 2917: 2911: 2904: 2902: 2896: 2889: 2887: 2881: 2874: 2872: 2866: 2859: 2857: 2851: 2844: 2842: 2836: 2829: 2827: 2821: 2814: 2812: 2806: 2799: 2797: 2791: 2784: 2782: 2776: 2769: 2767: 2761: 2754: 2751: 2748: 2747: 2744: 2742: 2741: 2734: 2727: 2719: 2713: 2712: 2689: 2688:External links 2686: 2684: 2683: 2644:(8): 4046–51. 2620: 2581:(3): 1235–40. 2561: 2502: 2461: 2412: 2358: 2323: 2274: 2244: 2195: 2143: 2099: 2037: 1998:(23): 8822–7. 1973: 1936:(4): 930–937. 1916: 1864: 1805: 1770: 1756: 1721:ACS Chem. Biol 1700: 1682: 1664: 1643: 1621: 1619: 1616: 1615: 1614: 1609: 1602: 1599: 1597: 1596: 1590: 1584: 1578: 1572: 1566: 1559: 1550: 1547: 1530: 1527: 1498:is frequently 1384: 1381: 1372: 1369: 1324:Main article: 1321: 1318: 1282:and sites for 1249: 1246: 1240: 1237: 1209: 1208: 1205: 1204: 1199: 1189: 1188: 1182: 1181: 1178: 1177: 1175: 1173: 1166: 1165: 1158: 1151: 1147: 1146: 1143: 1142: 1132: 1131: 1125: 1122: 1121: 1111: 1110: 1104: 1100: 1099: 1096: 1095: 1085: 1084: 1078: 1075: 1074: 1064: 1063: 1057: 1053: 1052: 1049: 1048: 1040: 1039: 1033: 1030: 1029: 1021: 1020: 1014: 1008: 1007: 1004: 1003: 995: 994: 988: 985: 984: 976: 975: 969: 963: 962: 959: 958: 950: 949: 943: 940: 939: 931: 930: 924: 918: 917: 912: 907: 903: 902: 892: 891: 888: 887: 876: 875: 873: 872: 867: 862: 857: 852: 847: 842: 837: 832: 827: 822: 817: 812: 806: 804: 800: 799: 797: 796: 791: 786: 781: 776: 771: 766: 761: 756: 751: 746: 741: 735: 733: 729: 728: 726: 725: 720: 715: 710: 705: 700: 695: 690: 685: 680: 675: 670: 665: 660: 655: 649: 647: 643: 642: 632: 631: 628: 627: 624: 623: 620: 619: 612: 606: 605: 602: 601: 593: 592: 589: 588: 586: 585: 581: 577: 573: 569: 568:tail of embryo 565: 561: 557: 553: 549: 545: 542: 541: 530: 527: 526: 524: 523: 519: 515: 511: 507: 503: 499: 495: 491: 487: 483: 480: 479: 467: 466: 458: 447: 441: 440: 437:RNA expression 429: 428: 425: 424: 416: 412: 411: 403: 400: 395: 389: 388: 379: 372: 366: 362: 361: 356: 350: 349: 341: 340: 328: 327: 324: 323: 315: 311: 310: 302: 299: 294: 288: 287: 278: 271: 265: 261: 260: 253: 247: 246: 238: 237: 225: 224: 181: 177: 176: 168: 160: 159: 155: 154: 151: 150: 147: 146: 80: 79: 71: 70: 59: 53: 52: 44: 43: 35: 34: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 3008: 2997: 2994: 2993: 2991: 2974: 2968: 2963: 2959: 2953: 2948: 2944: 2938: 2933: 2929: 2923: 2918: 2914: 2908: 2903: 2899: 2893: 2888: 2884: 2878: 2873: 2869: 2863: 2858: 2854: 2848: 2843: 2839: 2833: 2828: 2824: 2818: 2813: 2809: 2803: 2798: 2794: 2788: 2783: 2779: 2773: 2768: 2764: 2758: 2753: 2749: 2740: 2735: 2733: 2728: 2726: 2721: 2720: 2717: 2710: 2706: 2705: 2700: 2696: 2692: 2691: 2687: 2679: 2675: 2670: 2665: 2660: 2655: 2651: 2647: 2643: 2639: 2635: 2631: 2624: 2621: 2616: 2612: 2607: 2602: 2597: 2592: 2588: 2584: 2580: 2576: 2572: 2565: 2562: 2557: 2553: 2548: 2543: 2538: 2533: 2529: 2525: 2521: 2517: 2513: 2506: 2503: 2498: 2494: 2489: 2484: 2481:(4): 1993–7. 2480: 2476: 2472: 2465: 2462: 2457: 2453: 2448: 2443: 2439: 2435: 2432:(7): 1841–7. 2431: 2427: 2423: 2416: 2413: 2408: 2404: 2399: 2394: 2389: 2384: 2380: 2376: 2372: 2365: 2363: 2359: 2354: 2350: 2346: 2342: 2339:(4): 677–86. 2338: 2334: 2327: 2324: 2319: 2315: 2310: 2305: 2301: 2297: 2293: 2289: 2285: 2278: 2275: 2270: 2266: 2263:(5): 976–84. 2262: 2258: 2251: 2249: 2245: 2240: 2236: 2231: 2226: 2222: 2218: 2214: 2210: 2206: 2199: 2196: 2191: 2187: 2182: 2177: 2173: 2169: 2166:(5): 401–10. 2165: 2161: 2157: 2150: 2148: 2144: 2139: 2135: 2130: 2125: 2121: 2117: 2113: 2106: 2104: 2100: 2095: 2091: 2086: 2081: 2076: 2071: 2067: 2063: 2059: 2055: 2051: 2044: 2042: 2038: 2033: 2029: 2024: 2019: 2014: 2009: 2005: 2001: 1997: 1993: 1989: 1982: 1980: 1978: 1974: 1969: 1965: 1960: 1955: 1951: 1947: 1943: 1939: 1935: 1931: 1927: 1920: 1917: 1912: 1908: 1903: 1898: 1894: 1890: 1887:(4): 753–89. 1886: 1882: 1878: 1871: 1869: 1865: 1860: 1856: 1851: 1846: 1841: 1836: 1832: 1828: 1824: 1820: 1816: 1809: 1806: 1801: 1797: 1793: 1789: 1785: 1781: 1774: 1771: 1766: 1760: 1757: 1752: 1748: 1743: 1738: 1734: 1730: 1726: 1722: 1718: 1711: 1709: 1707: 1705: 1701: 1696: 1692: 1686: 1683: 1678: 1674: 1668: 1665: 1661: 1657: 1652: 1650: 1648: 1644: 1640: 1636: 1631: 1629: 1627: 1623: 1617: 1613: 1612:Topoisomerase 1610: 1608: 1605: 1604: 1600: 1594: 1591: 1588: 1585: 1582: 1579: 1576: 1573: 1570: 1567: 1564: 1561: 1560: 1558: 1556: 1548: 1546: 1544: 1540: 1536: 1528: 1526: 1523: 1519: 1518: 1512: 1509: 1505: 1501: 1497: 1496: 1491: 1487: 1482: 1480: 1476: 1472: 1468: 1464: 1460: 1457: 1453: 1452: 1446: 1444: 1440: 1436: 1432: 1428: 1424: 1420: 1416: 1413: 1409: 1408: 1402: 1399: 1397: 1393: 1389: 1382: 1380: 1378: 1370: 1368: 1366: 1362: 1357: 1353: 1349: 1345: 1341: 1337: 1333: 1327: 1319: 1317: 1315: 1311: 1307: 1303: 1298: 1296: 1293: 1289: 1285: 1281: 1277: 1276: 1271: 1267: 1262: 1259: 1254: 1247: 1245: 1238: 1236: 1234: 1230: 1226: 1223: 1219: 1215: 1203: 1198: 1194: 1190: 1187: 1183: 1176: 1174: 1171: 1167: 1163: 1159: 1156: 1152: 1148: 1141: 1139: 1133: 1129: 1126: 1120: 1118: 1112: 1108: 1105: 1101: 1094: 1092: 1086: 1082: 1079: 1073: 1071: 1065: 1061: 1058: 1056:RefSeq (mRNA) 1054: 1047: 1046: 1041: 1037: 1034: 1028: 1027: 1022: 1018: 1015: 1013: 1009: 1002: 1001: 996: 992: 989: 983: 982: 977: 973: 970: 968: 964: 957: 956: 951: 947: 944: 938: 937: 932: 928: 925: 923: 919: 916: 913: 911: 908: 904: 901: 897: 893: 886: 882: 877: 871: 868: 866: 863: 861: 860:viral process 858: 856: 853: 851: 848: 846: 843: 841: 838: 836: 833: 831: 828: 826: 823: 821: 818: 816: 813: 811: 808: 807: 805: 802: 801: 795: 792: 790: 787: 785: 782: 780: 777: 775: 772: 770: 767: 765: 762: 760: 757: 755: 752: 750: 747: 745: 742: 740: 737: 736: 734: 731: 730: 724: 721: 719: 716: 714: 711: 709: 706: 704: 701: 699: 696: 694: 691: 689: 686: 684: 681: 679: 676: 674: 671: 669: 666: 664: 661: 659: 656: 654: 651: 650: 648: 645: 644: 641: 640:Gene ontology 637: 633: 621: 616: 613: 611: 607: 599: 594: 583: 579: 575: 571: 567: 563: 559: 555: 551: 547: 546: 543: 539: 534: 531: 521: 517: 513: 509: 505: 501: 497: 493: 489: 485: 484: 481: 477: 472: 469: 468: 465: 463: 459: 457: 456: 452: 451: 448: 446: 442: 438: 434: 430: 422: 417: 413: 409: 404: 394: 390: 383: 376: 370: 363: 355: 351: 347: 342: 338: 333: 329: 321: 316: 312: 308: 303: 293: 289: 282: 275: 269: 262: 258: 252: 248: 244: 239: 235: 230: 226: 222: 218: 214: 210: 206: 202: 198: 194: 190: 186: 178: 173: 166: 161: 156: 145: 143: 139: 135: 131: 127: 123: 119: 115: 111: 107: 103: 99: 95: 91: 87: 81: 76: 73: 72: 68: 65: 58: 54: 49: 45: 41: 36: 31: 19: 2972: 2957: 2942: 2927: 2912: 2897: 2882: 2867: 2852: 2837: 2822: 2807: 2792: 2777: 2762: 2702: 2641: 2637: 2632:(Apr 2000). 2623: 2578: 2574: 2564: 2519: 2515: 2505: 2478: 2474: 2464: 2429: 2425: 2415: 2378: 2375:BMC Genomics 2374: 2336: 2332: 2326: 2291: 2287: 2277: 2260: 2256: 2215:(1): 52–60. 2212: 2208: 2198: 2163: 2159: 2119: 2115: 2057: 2053: 1995: 1991: 1933: 1929: 1919: 1884: 1880: 1822: 1818: 1808: 1783: 1779: 1773: 1759: 1727:(1): 82–95. 1724: 1720: 1694: 1685: 1676: 1667: 1552: 1549:Interactions 1532: 1521: 1515: 1513: 1507: 1494: 1486:pre-clinical 1483: 1481:deficiency. 1478: 1474: 1470: 1466: 1449: 1447: 1438: 1434: 1430: 1426: 1422: 1414: 1406: 1403: 1400: 1386: 1374: 1361:Camptothecin 1343: 1340:camptothecin 1329: 1310:supercoiling 1299: 1273: 1270:supercoiling 1263: 1255: 1251: 1242: 1221: 1213: 1212: 1135: 1114: 1088: 1067: 1043: 1024: 998: 979: 953: 934: 914: 909: 460: 453: 419:160,564,684 406:160,487,808 180:External IDs 83: 2745:PDB gallery 1881:Med Res Rev 1786:: 369–413. 1306:nucleophile 1292:active site 779:nucleoplasm 708:ATP binding 688:DNA binding 683:RNA binding 572:human fetus 502:pericardium 318:41,124,487 305:41,028,822 158:Identifiers 2209:Aging Cell 1662:, May 2017 1641:, May 2017 1618:References 1529:DNA repair 1490:epigenetic 1421:(silenced 1336:irinotecan 1332:inhibitors 1320:Inhibition 1314:religation 1266:N-terminal 1227:. It is a 759:chromosome 744:perikaryon 464:(ortholog) 201:HomoloGene 1950:1097-0215 1581:Nucleolin 1419:promoters 1377:topotecan 1348:metabolic 1272:activity 1248:Mechanism 1138:NP_033434 1117:NP_003277 1091:NM_009408 1070:NM_003286 900:Orthologs 784:nucleolus 739:cytoplasm 510:vena cava 209:GeneCards 2990:Category 2678:10759568 2615:11805286 2556:10468612 2407:11818025 2353:12270705 2239:27618784 2190:23377825 2138:27638859 2094:25310185 2054:PLOS ONE 2032:16723399 1968:27859136 1911:25808858 1859:22991469 1800:11395412 1751:23259582 1658:– 1637:– 1601:See also 1555:interact 1508:in vitro 1456:adjuvant 1392:mutation 1350:product 1288:tyrosine 1275:in vitro 1239:Function 1186:Wikidata 879:Sources: 522:monocyte 2709:PDBe-KB 2699:UniProt 2646:Bibcode 2583:Bibcode 2524:Bibcode 2497:8567649 2456:9512561 2318:9611241 2269:9500459 2230:5242303 2181:3672184 2085:4195600 2062:Bibcode 2023:1466544 2000:Bibcode 1959:5299512 1902:4465867 1850:3479559 1827:Bibcode 1742:3549721 1660:Ensembl 1639:Ensembl 1563:ASF/SF2 1012:UniProt 967:Ensembl 906:Species 885:QuickGO 769:nucleus 506:pylorus 439:pattern 165:Aliases 2704:P11387 2676:  2666:  2630:Liu LF 2613:  2606:122173 2603:  2554:  2544:  2495:  2454:  2447:147454 2444:  2405:  2395:  2351:  2316:  2309:147637 2306:  2267:  2237:  2227:  2188:  2178:  2136:  2092:  2082:  2030:  2020:  1966:  1956:  1948:  1909:  1899:  1857:  1847:  1798:  1749:  1739:  1589:, and 1557:with: 1371:Cancer 1218:enzyme 1216:is an 1172:search 1170:PubMed 1045:Q04750 1026:P11387 922:Entrez 749:P-body 610:BioGPS 552:zygote 486:oocyte 189:126420 2669:18143 2547:17892 2398:64781 2381:: 1. 1593:UBE2I 1575:BTBD2 1569:BTBD1 1522:NDRG1 1517:NDRG1 1479:MRE11 1475:MRE11 1471:MRE11 1467:MRE11 1463:MRE11 1459:bolus 1451:MRE11 1417:gene 1356:SN-38 1352:SN-38 955:21969 915:Mouse 910:Human 881:Amigo 462:Mouse 455:Human 402:Start 337:Mouse 301:Start 297:20q12 234:Human 197:98788 2973:1tl8 2958:1t8i 2943:1seu 2928:1sc7 2913:1rrj 2898:1rr8 2883:1r49 2868:1nh3 2853:1lpq 2838:1k4t 2823:1k4s 2808:1ej9 2793:1a36 2778:1a35 2763:1a31 2697:for 2674:PMID 2611:PMID 2552:PMID 2493:PMID 2452:PMID 2403:PMID 2349:PMID 2314:PMID 2265:PMID 2235:PMID 2186:PMID 2134:PMID 2090:PMID 2028:PMID 1964:PMID 1946:ISSN 1907:PMID 1855:PMID 1796:PMID 1747:PMID 1225:gene 1222:TOP1 936:7150 445:Bgee 393:Band 354:Chr. 292:Band 251:Chr. 213:TOP1 205:2467 185:OMIM 172:TOP1 142:1TL8 138:1T8I 134:1SEU 130:1SC7 126:1RRJ 122:1RR8 118:1R49 114:1NH3 110:1LPQ 106:1K4T 102:1K4S 98:1EJ9 94:1A36 90:1A35 86:1A31 67:RCSB 64:PDBe 33:TOP1 2695:PDB 2664:PMC 2654:doi 2601:PMC 2591:doi 2542:PMC 2532:doi 2483:doi 2479:271 2442:PMC 2434:doi 2393:PMC 2383:doi 2341:doi 2337:322 2304:PMC 2296:doi 2225:PMC 2217:doi 2176:PMC 2168:doi 2124:doi 2080:PMC 2070:doi 2018:PMC 2008:doi 1996:103 1954:PMC 1938:doi 1934:140 1897:PMC 1889:doi 1845:PMC 1835:doi 1823:109 1788:doi 1737:PMC 1729:doi 1587:P53 1539:DNA 1535:UVB 1495:ATM 1439:WRN 1435:WRN 1431:WRN 1427:WRN 1423:WRN 1415:WRN 1407:WRN 1295:Tyr 1233:DNA 618:n/a 415:End 314:End 217:OMA 193:MGI 57:PDB 2992:: 2701:: 2672:. 2662:. 2652:. 2642:97 2640:. 2636:. 2609:. 2599:. 2589:. 2579:99 2577:. 2573:. 2550:. 2540:. 2530:. 2520:96 2518:. 2514:. 2491:. 2477:. 2473:. 2450:. 2440:. 2430:26 2428:. 2424:. 2401:. 2391:. 2377:. 2373:. 2361:^ 2347:. 2335:. 2312:. 2302:. 2292:26 2290:. 2286:. 2261:58 2259:. 2247:^ 2233:. 2223:. 2213:16 2211:. 2207:. 2184:. 2174:. 2164:14 2162:. 2158:. 2146:^ 2132:. 2120:15 2118:. 2114:. 2102:^ 2088:. 2078:. 2068:. 2056:. 2052:. 2040:^ 2026:. 2016:. 2006:. 1994:. 1990:. 1976:^ 1962:. 1952:. 1944:. 1932:. 1928:. 1905:. 1895:. 1885:35 1883:. 1879:. 1867:^ 1853:. 1843:. 1833:. 1821:. 1817:. 1794:. 1784:70 1782:. 1745:. 1735:. 1723:. 1719:. 1703:^ 1693:. 1675:. 1646:^ 1625:^ 1445:. 1394:, 1235:. 883:/ 421:bp 408:bp 320:bp 307:bp 215:; 211:: 207:; 203:: 199:; 195:: 191:; 187:: 140:, 136:, 132:, 128:, 124:, 120:, 116:, 112:, 108:, 104:, 100:, 96:, 92:, 88:, 2738:e 2731:t 2724:v 2711:. 2680:. 2656:: 2648:: 2617:. 2593:: 2585:: 2558:. 2534:: 2526:: 2499:. 2485:: 2458:. 2436:: 2409:. 2385:: 2379:3 2355:. 2343:: 2320:. 2298:: 2271:. 2241:. 2219:: 2192:. 2170:: 2140:. 2126:: 2096:. 2072:: 2064:: 2058:9 2034:. 2010:: 2002:: 1970:. 1940:: 1913:. 1891:: 1861:. 1837:: 1829:: 1802:. 1790:: 1767:. 1753:. 1731:: 1725:8 1697:. 1679:. 1595:. 1583:, 1577:, 1571:, 1565:, 339:) 236:) 219:: 20:)

Index

Topoisomerase I

PDB
PDBe
RCSB
1A31
1A35
1A36
1EJ9
1K4S
1K4T
1LPQ
1NH3
1R49
1RR8
1RRJ
1SC7
1SEU
1T8I
1TL8
Aliases
TOP1
OMIM
126420
MGI
98788
HomoloGene
2467
GeneCards
TOP1

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.